RNA Formulation Solutions
-
Complete Solutions For Every Step Of Pharmaceutical Development
1/12/2023
By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.
-
Labscale Lipid Nanoparticle Production: IJM NanoScaler
12/9/2024
The benchtop IJM NanoScaler system is designed for lipid nanoparticle R&D – allowing scientists to screen for the optimal process parameters for the formulation of API-containing lipid nanoparticles.
-
Metabolite And Lipid Analysis Service
10/29/2024
Unlock actionable insights into your cell culture process with metabolite and lipid analysis, enabling data-driven optimizations for growth, titer, and product quality.
-
CD34+ HSC LNP Kits
4/24/2025
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
Contract Services To Optimize Continuous Nanoparticle Processing
10/16/2025
DIANT Pharma provides continuous manufacturing systems and technical services for nanoparticle-based formulations. The company’s platform supports both research and manufacturing teams working on lipid nanoparticles (LNPs), liposomes, polymeric micelles, nucleic acid–lipid complexes, and other colloidal systems.
-
Leveraging Transformational Formulation Technologies: LNPs
2/16/2023
Increasingly we are seeing customers that are looking for specialized formulation capabilities and, specifically, expertise in developing lipid nanoparticles. August Bio can work with a range of LNP formulation and sizing technologies to achieve the desired product profile.
-
in vivo mRNA Delivery Using Liposome-Based Reagent
12/12/2022
in vivo-jetRNA®+ is a ready-to-use reagent that does not require formulation equipment that leads to 100% mRNA encapsulation leading to efficient mRNA delivery.
-
DasherGRP mRNA: Optimized Fluorescent Protein
5/6/2026
Fluorescent mRNA reporters enable rapid visual confirmation of delivery and expression in mammalian cells, with bright signal, transient expression, and quantitative readouts.
-
Pre-GMP mRNA And LNP Development
11/26/2024
Leverage Pre-GMP mRNA and LNP development services to streamline process development, mitigate risks early, and accelerate your path to market with high-quality, compliant drug products.
-
Jet-Based Nanoparticle Formulation At Research Scale
8/14/2025
Developing nanoparticle formulations requires a scalable solution that replicates manufacturing conditions at a small scale. Turbulent jet mixing enables linear scalability while conserving materials.